|
Search |
Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals said, "During this past quarter, we demonstrated significant progress with the exenatide program. Specifically, the recent approval of BYDUREON in
Amylin Pharmaceuticals (NASDAQ:AMLN) reported Q2 loss of $0.21 per share, wider than analyst estimate loss of $0.18. Revenues for the quarter rose 2.1% to $158.10, better than consensus estimates of $157.72 million.
The companies' proposal is to grow the use of its diabetes treatment Byetta as "an add-on therapy to basal insulin."
Byetta was approved in April 2005 in the U.S. for type 2 diabetes treatment.
Amylin's senior vice president and chief medical officer, Orville G. Kolterman, M.D.
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Eli Lilly & Co. (NYSE:LLY) submitted a supplemental New Drug Application to the U.S. Food and Drug Administration this week, Bloomberg reports Thursday.
 |
When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...
 |
A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...
 |
When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...
 |
When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...
 |
A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...
 |
When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...
 |
A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...
 |
11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...
CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.
Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...
